Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
>1%
EC/CAS
1305-62-0
Name of the chemical
Calcium dihydroxide
Concentration
<1%
General Information
Revision date
2015-11-04
Product name
QUADRAMET (Samarium Sm-153 Lexidronam Injection)
1.2.1 Relevant identified uses
This material is used as a medical imaging agent. It is a radioactive isotope of Samarium (Sm-153)
Icons in SDS
Company Information
company name
Lantheus Medical Imaging
GHS Information
Signal word
Danger!
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW: Appearance Clear, colorless to light yellow liquid
Signal word
Danger!
Hazard statements
Radioactive, Corrosive
Precautionary statements
Avoid ingestion, inhalation, skin and eye contact. Wear eye/face protection. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves. After contact with skin, wash immediately with plenty of water. Wash hands after handling to minimize exposure. Care should be taken to minimize radiation exposure. Pregnant or nursing women should avoid exposure. Appropriate radiation shielding should be used. Keep material in a lead container. Avoid direct handling by using remote manipulation tools.
Potential health effects
Eyes Corrosive Skin Corrosive Ingestion Exposure to radioactive materials may produce adverse effects. Inhalation Exposure to radioactive materials may produce adverse effects. Target Organs Bones, bone marrow, kidney. Signs and Symptoms Acute: severe burns, tissue destruction, blindness, corneal opacity, redness and swelling of skin and eyes, labored respiration, noisy respiration, chest pain, breathing difficulties, shortness of breath, lung inflammation, oedema, pneumonia. Chronic Radioactive material may cause cancer, adverse reproductive effects, embryo/fetal toxicity.
Environmental effects
Not Available
